Eva Glud

710 total citations
15 papers, 523 citations indexed

About

Eva Glud is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Eva Glud has authored 15 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Reproductive Medicine and 4 papers in Molecular Biology. Recurrent topics in Eva Glud's work include Ovarian cancer diagnosis and treatment (8 papers), Cancer-related Molecular Pathways (5 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Eva Glud is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Cancer-related Molecular Pathways (5 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Eva Glud collaborates with scholars based in Denmark, United Kingdom and United States. Eva Glud's co-authors include Susanne K. Kjær, Claus Høgdall, Estrid Høgdall, Jan Blaakær, Lise Christensen, Johannes E. Bock, Kirsten Frederiksen, P. A. Price, Jens Vuust and Birthe Lykke Thomsen and has published in prestigious journals such as Cancer, Gynecologic Oncology and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

Eva Glud

15 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Glud Denmark	13	272	244	196	100	85	15	523
Kristina Levan Sweden	14	178 0.7×	106 0.4×	223 1.1×	150 1.5×	63 0.7×	17	463
Jonathan G. Bijron United States	8	437 1.6×	164 0.7×	235 1.2×	141 1.4×	72 0.8×	13	667
Robert L. Hollis United Kingdom	15	431 1.6×	256 1.0×	255 1.3×	138 1.4×	68 0.8×	32	695
Terry Hurst Australia	11	202 0.7×	157 0.6×	276 1.4×	63 0.6×	54 0.6×	18	477
Adriaan Vanderstichele Belgium	14	266 1.0×	300 1.2×	288 1.5×	327 3.3×	93 1.1×	29	752
Peter Schlosshauer United States	12	209 0.8×	110 0.5×	270 1.4×	53 0.5×	53 0.6×	20	568
Jane Ramsdale United Kingdom	6	87 0.3×	183 0.8×	237 1.2×	62 0.6×	59 0.7×	8	436
L. Moretti Belgium	9	79 0.3×	144 0.6×	148 0.8×	38 0.4×	57 0.7×	23	457
Sarah J. Morland United Kingdom	4	437 1.6×	89 0.4×	298 1.5×	64 0.6×	96 1.1×	6	658

Countries citing papers authored by Eva Glud

Since Specialization

Citations

This map shows the geographic impact of Eva Glud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Glud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Glud more than expected).

Fields of papers citing papers by Eva Glud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Glud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Glud. The network helps show where Eva Glud may publish in the future.

Co-authorship network of co-authors of Eva Glud

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Glud. A scholar is included among the top collaborators of Eva Glud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Glud. Eva Glud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Faber, Mette Tuxen, Allan Jensen, Kirsten Frederiksen, et al.. (2013). Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer. Cancer Causes & Control. 24(12). 2197–2206. 21 indexed citations

Huusom, Lene Drasbek, Kirsten Frederiksen, Estrid Høgdall, et al.. (2006). Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-control Study. Cancer Causes & Control. 17(6). 821–829. 35 indexed citations

Kjærbye‐Thygesen, Anette, Kirsten Frederiksen, Estrid Høgdall, et al.. (2006). Smoking and Overweight: Negative Prognostic Factors in Stage III Epithelial Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 15(4). 798–803. 45 indexed citations

Høgdall, Estrid, Susanne K. Kjær, Jan Blaakær, et al.. (2005). P53 mutations in tissue from Danish ovarian cancer patients. Gynecologic Oncology. 100(1). 76–82. 13 indexed citations

Høgdall, Estrid, Andy Ryan, Susanne K. Kjær, et al.. (2004). Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma. Cancer. 100(11). 2387–2395. 14 indexed citations

Glud, Eva, Susanne K. Kjær, Birthe Lykke Thomsen, et al.. (2004). Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer. Archives of Internal Medicine. 164(20). 2253–2253. 63 indexed citations

Høgdall, Claus, Susanne K. Kjær, Lise Christensen, et al.. (2004). The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.. PubMed. 24(3b). 1981–5. 32 indexed citations

Høgdall, Estrid, Claus Høgdall, Jan Blaakær, et al.. (2003). K-ras alterations in Danish ovarian tumour patients.. Gynecologic Oncology. 89(1). 31–36. 18 indexed citations

Høgdall, Estrid, Lise Christensen, Susanne K. Kjær, et al.. (2003). Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma. Cancer. 98(1). 66–73. 111 indexed citations

10.

Høgdall, Estrid, Susanne K. Kjær, Eva Glud, et al.. (2003). Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.. PubMed. 23(4). 3397–404. 10 indexed citations

11.

Høgdall, Estrid, Julia S. Johansen, Susanne K. Kjær, et al.. (2003). High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncology Reports. 10(5). 1535–8. 76 indexed citations

12.

Høgdall, Estrid, Claus Høgdall, Jan Blaakær, et al.. (2002). P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis. Apmis. 110(7-8). 545–553. 24 indexed citations

13.

Høgdall, Estrid, Claus Høgdall, Lise Christensen, et al.. (2002). Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.. PubMed. 22(3). 1859–64. 28 indexed citations

14.

Glud, Eva, et al.. (1998). Fertility Drugs and Ovarian Cancer. Epidemiologic Reviews. 20(2). 237–257. 32 indexed citations

15.

Glud, Eva & Marge Ewertz. (1992). [P-pills and risk of breast cancer. A review of studies published 1970-1990].. PubMed. 154(5). 260–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact